MARÍA DE LOS DOLORES PÉREZ ALENZA-rekin lankidetzan egindako argitalpenak (9)

2024

  1. Prevalence of Systemic Hypertension and Control of Systolic Blood Pressure in a Cohort of 14 Dogs with Adrenal-Dependent Hypercortisolism during the First Year of Trilostane Treatment or after Adrenalectomy

    Animals, Vol. 14, Núm. 3

2023

  1. Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients

    Cells, Vol. 12, Núm. 18

  2. Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate

    Veterinary and Comparative Oncology, Vol. 20, Núm. 1, pp. 179-188

  2. Epitheliosis is a histopathological finding associated with malignancy and poor prognosis in dogs with mammary tumors

    Veterinary Pathology, Vol. 59, Núm. 5, pp. 747-758

  3. Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

    Journal for immunotherapy of cancer, Vol. 10, Núm. 3

  4. Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane

    Veterinary Record, Vol. 191, Núm. 3, pp. no

2021

  1. Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment

    Journal of Veterinary Internal Medicine, Vol. 35, Núm. 1, pp. 130-141

  2. Evaluation of palliative therapy, alone or in combination with toceranib phosphate, in dogs diagnosed with metastatic or recurrent beta-cell neoplasia

    New Zealand Veterinary Journal, Vol. 69, Núm. 4, pp. 234-239